Literature DB >> 3581566

Complications associated with warfarin prophylaxis in total knee arthroplasty.

C J Sutherland, J R Schurman.   

Abstract

Systemic and local complications associated with the use of warfarin for deep vein thrombosis prophylaxis in total knee arthroplasty (TKA) are significant. Forty-seven patients with primary TKAs considered at high risk for developing thromboembolic disease were treated with a regimen of preoperative and postoperative warfarin. The incidence (n = 2) of systemic complications was 4%. The incidence (n = 6) of wound complications requiring specific treatment or discontinuing physiotherapy was 12%. In this series, wound complications did not jeopardize the end results of TKA. However, such wound complications as may have delayed recovery occurred with a frequency similar to that reported in other series of TKA using different antithromboembolic modalities.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3581566

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Retrospective analysis of the clinical course for intubation vs. unspecified laryngeal granulomas.

Authors:  Yoshihiko Kumai; Eiji Yumoto; Kohei Nishimoto; Ryosei Minoda
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05       Impact factor: 2.503

2.  Comparision of blood loss between computer assisted and conventional total knee arthroplasty.

Authors:  Paras Kumar Mohanlal; Nemandra Sandiford; John A Skinner; Sr Samsani
Journal:  Indian J Orthop       Date:  2013-01       Impact factor: 1.251

3.  Discontinuation of warfarin is unnecessary in total knee arthroplasty.

Authors:  David A Rhodes; Erik P Severson; Jeffrey T Hodrick; Harold K Dunn; Aaron A Hofmann
Journal:  Clin Orthop Relat Res       Date:  2010-01       Impact factor: 4.176

4.  Release of the tourniquet immediately after the implantation of the components reduces the incidence of deep vein thrombosis after primary total knee arthroplasty.

Authors:  P Zan; M O Mol; J J Yao; L Fan; D Yang; K Liu; G Li
Journal:  Bone Joint Res       Date:  2017-09       Impact factor: 5.853

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.